Reciprocal effects of IFN-β and IL-12 on STAT4 activation and cytokine induction in T cells
IL‐12 is an immunoregulatory cytokine, which promotes Th1 cell differentiation and is a major inducer of IFN‐γ. IFN‐β, a Type I IFN used in the treatment of multiple sclerosis, has been shown to significantly increase the expression of the anti‐inflammatory cytokine IL‐10, a major suppressor of Th1...
Gespeichert in:
Veröffentlicht in: | Journal of leukocyte biology 2007-06, Vol.81 (6), p.1562-1567 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | IL‐12 is an immunoregulatory cytokine, which promotes Th1 cell differentiation and is a major inducer of IFN‐γ. IFN‐β, a Type I IFN used in the treatment of multiple sclerosis, has been shown to significantly increase the expression of the anti‐inflammatory cytokine IL‐10, a major suppressor of Th1 cytokines. The beneficial immunomodulatory effects of IFN‐β may in part be a result of its ability to suppress IL‐12. However, IL‐12 and IFN‐β signal via the STAT4 pathway. Our aim was to investigate the relationship between IL‐12 and IFN‐β by observing the effect of prior exposure to IL‐12 or IFN‐β on the ability of T cells to subsequently respond to the other cytokine. We report that IFN‐β increases IL‐12‐induced STAT4 phosphorylation and up‐regulates IL‐12 receptor β1 and β2 expression. However, despite this up‐regulation, IFN‐β suppressed IL‐12‐induced IFN‐γ expression. Our results suggest that this may be a result of the parallel induction of IL‐10 by IFN‐β. |
---|---|
ISSN: | 0741-5400 1938-3673 |
DOI: | 10.1189/jlb.1006633 |